cb-012
caribou
['cb-012', 'cll', 'caribou']
caribou biosciences presents new preclinical data on cb-012, an allogeneic anti-cll-1 car-t cell therapy, at the 2023 aacr annual meeting $crbu via 
Managed Corporate Credit currently a Trader / Investor. Mostly using my Feed to Journal my DayTrading Notes. Watch List Summary Posted Most Weekdays by 9am EST.